Xin Lang Cai Jing·2026-01-04 11:47Group 1 - The company held an investor meeting on January 4, 2026, to discuss business progress, performance planning, and technology layout with institutional investors [1] - Key participants included the company's Vice General Manager and Board Secretary, Investment Director, and heads of various departments [1] Group 2 - The joint venture company is focused on developing next-generation edge brain-machine interface algorithm chips and advancing mixed biometric and brain signal analysis [2] - The joint venture is currently in the process of business registration [2] Group 3 - The company has set its 2026 performance targets based on the 2025 restricted stock incentive plan and employee stock ownership plan [3] - To achieve these targets, the company plans to leverage AI technology, enhance brand influence, and expand market space [3] Group 4 - The performance assessment for the stock incentive plan excludes results from acquisitions, focusing instead on the company's organic growth capabilities [4] Group 5 - The company's non-invasive brain-machine business leverages long-term AI cognitive computing expertise, focusing on BioCV TinyML edge model development [5] - This approach aims to optimize brain-machine interaction across various elements by integrating perception, analysis, and decision-making capabilities into edge devices [5] Group 6 - The partnership with ShenNian Technology is based on its 20 years of industry experience, strong data accumulation, and a cross-disciplinary team [6] - ShenNian's business model, which combines chips and algorithm SDKs, has been successfully validated [6] Group 7 - The company has not yet adopted digital RMB for cross-border settlements and is managing exchange rate risks through global supply chain strategies and local operations [7] - The company employs various methods to hedge against currency risks, including forward foreign exchange contracts and attempts at cross-border RMB settlements [7]